Baidu
map

卫生部印发《原发性肺癌诊疗质量控制指标(试行)》

2012-05-10 卢秀玲 中华人民共和国卫生部

卫生部办公厅关于印发《原发性肺癌诊疗质量控制指标(试行)》的通知 卫办医政函〔2012〕292号  各省、自治区、直辖市卫生厅局,新疆生产建设兵团卫生局:        为规范我国原发性肺癌临床诊疗行为,保障医疗质量和医疗安全,2011年我部制定印发了《原发性肺癌诊疗规范(2011年版)》,为进一步提高我国医疗机构原发性肺癌的诊疗水平,保障诊

卫生部办公厅关于印发《原发性肺癌诊疗质量控制指标(试行)》的通知

卫办医政函〔2012〕292号 

各省、自治区、直辖市卫生厅局,新疆生产建设兵团卫生局:

       为规范我国原发性肺癌临床诊疗行为,保障医疗质量和医疗安全,2011年我部制定印发了《原发性肺癌诊疗规范(2011年版)》,为进一步提高我国医疗机构原发性肺癌的诊疗水平,保障诊疗质量控制工作的顺利开展,我部组织专家制定了《原发性肺癌诊疗质量控制指标(试行)》(可从卫生部网站下载)。现印发给你们,供卫生行政部门和医疗机构在原发性肺癌诊疗质量管理控制工作中使用。请各省级卫生行政部门将执行过程中的有关情况及时汇总并反馈我部医政司。

       联 系 人:卫生部医政司医疗管理处  王斐、焦雅辉

       联系电话:010-68792413、68792097

二〇一二年四月一日
 
原发性肺癌诊疗质量控制指标(试行)
 
       一、治疗前实施临床分期检查。

       二、治疗前明确病理诊断,降低病理学不能分类的非小细胞肺癌诊断率。切除病灶的病理报告符合规范。

       三、完全性切除手术(R0手术)符合规范,严格掌握IIIA期手术患者适应证。

       四、不可手术的局部晚期原发性肺癌接受规范的化疗、放疗联合治疗。

       五、晚期肺癌化疗分线治疗符合规范。

       六、分子靶向药物的治疗方案符合规范。

       七、严格掌握各项治疗措施与药物的适应证。

       八、应当记录治疗的不良反应、并发症、临床获益、客观疗效(按RECIST标准评价)和患者生存期。

       九、为患者提供肺癌诊疗相关的健康教育。

       十、患者住院天数与住院费用。
 

《原发性肺癌诊疗质量控制指标(试行)》编写专家组
 
  组  长:吴一龙       广东省人民医院
       支修益  首都医科大学宣武医院

  参加人员:王长利       天津医科大学附属肿瘤医院
       王 洁  北京肿瘤医院
       朱广迎  北京肿瘤医院
       步 宏  四川大学华西医院   
       陈东红  首都医科大学宣武医院
                    杨衿记  广东省人民医院
                    金征宇  中国医学科学院北京协和医院
                    周云峰  武汉大学中南医院
                    程 颖  吉林省肿瘤医院    
                    韩宝惠  上海市胸科医院    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1846435, encodeId=ed3b18464352c, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Dec 31 11:20:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863112, encodeId=ab7418631126b, content=<a href='/topic/show?id=afe992396a2' target=_blank style='color:#2F92EE;'>#质量控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92396, encryptionId=afe992396a2, topicName=质量控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Fri Apr 12 21:20:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041033, encodeId=bd7b2041033a0, content=<a href='/topic/show?id=6cb591e236d' target=_blank style='color:#2F92EE;'>#诊疗质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91723, encryptionId=6cb591e236d, topicName=诊疗质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Feb 21 23:20:00 CST 2013, time=2013-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443277, encodeId=3fb414432e75b, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552958, encodeId=6fd1155295868, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1846435, encodeId=ed3b18464352c, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Dec 31 11:20:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863112, encodeId=ab7418631126b, content=<a href='/topic/show?id=afe992396a2' target=_blank style='color:#2F92EE;'>#质量控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92396, encryptionId=afe992396a2, topicName=质量控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Fri Apr 12 21:20:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041033, encodeId=bd7b2041033a0, content=<a href='/topic/show?id=6cb591e236d' target=_blank style='color:#2F92EE;'>#诊疗质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91723, encryptionId=6cb591e236d, topicName=诊疗质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Feb 21 23:20:00 CST 2013, time=2013-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443277, encodeId=3fb414432e75b, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552958, encodeId=6fd1155295868, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1846435, encodeId=ed3b18464352c, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Dec 31 11:20:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863112, encodeId=ab7418631126b, content=<a href='/topic/show?id=afe992396a2' target=_blank style='color:#2F92EE;'>#质量控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92396, encryptionId=afe992396a2, topicName=质量控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Fri Apr 12 21:20:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041033, encodeId=bd7b2041033a0, content=<a href='/topic/show?id=6cb591e236d' target=_blank style='color:#2F92EE;'>#诊疗质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91723, encryptionId=6cb591e236d, topicName=诊疗质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Feb 21 23:20:00 CST 2013, time=2013-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443277, encodeId=3fb414432e75b, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552958, encodeId=6fd1155295868, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1846435, encodeId=ed3b18464352c, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Dec 31 11:20:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863112, encodeId=ab7418631126b, content=<a href='/topic/show?id=afe992396a2' target=_blank style='color:#2F92EE;'>#质量控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92396, encryptionId=afe992396a2, topicName=质量控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Fri Apr 12 21:20:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041033, encodeId=bd7b2041033a0, content=<a href='/topic/show?id=6cb591e236d' target=_blank style='color:#2F92EE;'>#诊疗质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91723, encryptionId=6cb591e236d, topicName=诊疗质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Feb 21 23:20:00 CST 2013, time=2013-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443277, encodeId=3fb414432e75b, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552958, encodeId=6fd1155295868, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1846435, encodeId=ed3b18464352c, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Dec 31 11:20:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863112, encodeId=ab7418631126b, content=<a href='/topic/show?id=afe992396a2' target=_blank style='color:#2F92EE;'>#质量控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92396, encryptionId=afe992396a2, topicName=质量控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Fri Apr 12 21:20:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041033, encodeId=bd7b2041033a0, content=<a href='/topic/show?id=6cb591e236d' target=_blank style='color:#2F92EE;'>#诊疗质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91723, encryptionId=6cb591e236d, topicName=诊疗质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Feb 21 23:20:00 CST 2013, time=2013-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443277, encodeId=3fb414432e75b, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552958, encodeId=6fd1155295868, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Sat May 12 04:20:00 CST 2012, time=2012-05-12, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map